ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$248.68
Tradestie Score
43
Market Cap
$60.38B
P/E Ratio
45.1
Revenue Growth
0.7%
Analyst Upside
+49.3%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$984.39
|
$46.96B | 38.2 | 43 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$346.51
|
$36.81B | 62.9 | 48 | Compare |
|
INSM
Insmed, Inc.
|
$129.41
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.73
|
$24.57B | - | 37 | Compare |
|
GMAB
Genmab A/S ADS
|
$32.47
|
$19.56B | 26.2 | 41 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.47
|
$16.93B | 16.1 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.61
|
$15.70B | 32.6 | 52 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$17.55
|
$15.22B | - | 41 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$156.22
|
$13.59B | 22.7 | 60 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$263.52
|
$12.36B | 20.1 | 47 | Compare |
More ALNY Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry